Use of BII mAbs for Cancer Treatment (IMAGE)

Biomedical Sciences Institutes (BMSI)

Use of BII mAbs for Cancer Treatment

Caption

BTI's mAbs have a novel mechanism of action; causing membrane damage to cancer cells that result in cell death. The image on the left shows untreated cancer cells, while the image on the right depicts antibody-treated cancer cells with lesions and pores on the cell surface.

Credit

Bioprocessing Technology Institute, A*STAR

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.